Home > Healthcare > Analytical Instruments > Spectroscopy > Circular Dichroism (CD) Spectrometers Market

Circular Dichroism (CD) Spectrometers Market Size

Report ID: GMI8360
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Circular Dichroism (CD) Spectrometers Market Size

Circular Dichroism Spectrometers Market size was valued at around USD 39.9 million in 2023 and is expected to grow at a CAGR of 6.3% during the forecast period. The increasing popularity and demand for biologics is expected to be a key driving factor fueling the growth of the market.

To get key market trends

Download Free Sample

The growing popularity of biologics can be attributed to their effectiveness in treating various diseases, advancements in genetic testing and engineering, and increasing demand for personalized medicine options. Factors such as the increased prevalence of chronic diseases, aging population, expansion of biologics indications, and improvements in healthcare infrastructure, are driving the rising popularity of biologics worldwide.

Circular Dichroism Spectrometers Market Report Attributes
Report Attribute	Details
Base Year:	2023
Circular Dichroism Spectrometers Market Size in 2023:	USD 39.9 Million
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	6.3%
2032 Value Projection:	USD 70.3 Million
Historical Data for:	2018 - 2023
No. of Pages:	110
Tables, Charts & Figures:	188
Segments covered:	Product, Type, End-use, and Region
Growth Drivers:	Growing popularity of biologics Rising investments by private and public sectors in R&D of biopharmaceuticals Technological advancements in devices
Pitfalls & Challenges:	Lack of skilled professionals and specialized infrastructural facilities

Learn more about the key segments shaping this market

Download Free Sample

Biologics effectively manage chronic conditions such as cancer, autoimmune disorders, and infectious diseases, thereby improving patient outcomes and reducing healthcare costs, thus, further enhancing their popularity. These advantages of biologics are expected to propel the market for circular dichroism (CD) spectrometers.

Circular dichroism (CD) spectrometers are analytical instruments used to measure the difference in the absorption of left-handed circularly polarized light (L-CPL) and right-handed circularly polarized light (R-CPL) by chiral molecules. These molecules exhibit CD when they absorb different amounts of the two types of circularly polarized light due to their structural asymmetry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Circular dichroism (CD) spectrometers industry size was USD 39.9 million in 2023 and is expected to reach USD 70.3 million by 2032, due to the increasing popularity and the higher demand for biologics

The circularly polarized light sources segment is anticipated to record USD 32.7 million by 2032, owing to the rising research in fields such as biochemistry, biophysics, pharmaceuticals, and materials science.

North America CD spectrometers industry size was USD 21.4 million in 2023 and is predicted to witness substantial growth till 2032, due to the presence of numerous research institutions, academic centers, and pharmaceutical companies, particularly in the U.S.

Some of the eminent circular dichroism spectrometer providers include Jasco, Applied Photophysics Ltd., On-Line Instrument Systems, Inc. (Olis), Bruker Corporation, Bio-Logic Science Instrument, Inc, A.KRUSS Optronic GmbH, and Hinds Instruments, Inc.